OpenAI raises US$122b, company now worth US$852b

SAN FRANCISCO, April 1 -- OpenAI yesterday said that the startup was valued at US$852 billion (about RM3.44 trillion) in a freshly closed funding round that raised US$122 billion (about RM493 billion)... और पढ़ें

Singaporean Audrey Fang's suspected killer Mitchell Ong to remain in Spanish custody for two more years as investigation wraps up

SINGAPORE, April 1 -- The pre-trial detention of Mitchell Ong, the suspected killer of Singaporean Audrey Fang in 2024, has been extended by another two years in Spain, the court confirmed. The decis... और पढ़ें

LPG and aviation fuel prices rise sharply amid global energy disruptions

Mumbai, April 1 -- Amid ongoing global energy supply challenges, state-run oil marketing companies in India have increased prices of commercial LPG and aviation turbine fuel (ATF), leading to a sharp ... और पढ़ें

UAE Suspends All Visa Categories for Iranians Over Security Concerns

Afghanistan, April 1 -- The United Arab Emirates has suspended all visa categories for Iranian nationals, citing immediate travel and security measures amid heightened regional tensions. Flydubai sai... और पढ़ें

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... और पढ़ें

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... और पढ़ें

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... और पढ़ें

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... और पढ़ें

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... और पढ़ें

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... और पढ़ें

• ««
• «
• 10145
• 10146
• 10147
• 10148
• 10149
• 10150
• 10151
• 10152
• 10153
• 10154
• »
• »»